Jun 30, 2023

Featuring perspectives from Dr Matthew D Galsky, Prof Andrea Necchi and Dr Scott T Tagawa, including the following topics:

• Current and Future Management of Nonmetastatic Urothelial Bladder Cancer (UBC)
  • Introduction (0:00)
  • Management of non-muscle-invasive bladder cancer (5:30)
  • Neoadjuvant and adjuvant therapy...

Jun 29, 2023

Featuring perspectives from Dr Anthony El-Khoueiry, Dr Robin K (Katie) Kelley and Prof Arndt Vogel, includingthe following topics:

• Hepatocellular Carcinoma (HCC)
  • Introduction (0:00)
  • Adjuvant therapy for HCC (1:47)
  • First-line systemic therapy for advanced/metastatic HCC (10:36)
  • Management of HCC in the second-line...

Jun 27, 2023

Featuring perspectives from Dr Philipp Harter, Dr David M O’Malley and Dr Shannon N Westin, including the following topics:

• Up-Front Treatment for Advanced Ovarian Cancer (OC)
  • Introduction (0:00)
  • Front-line maintenance therapy for patients with advanced OC (3:11)
  • Adverse events associated with PARP inhibitors and...

Jun 26, 2023

Featuring perspectives from Dr Komal Jhaveri, Dr Kevin Kalinsky, Dr Ian E Krop, Dr Joyce O’Shaughnessy, Dr Hope S Rugo and Prof Peter Schmid, including the following topics:

• Long-Term Management of HER2-Positive Breast Cancer
  • Introduction (0:00)
  • Management of CNS-only disease progression in patients with...

Jun 22, 2023

Featuring perspectives from Ms Brenda Martone and Dr Jonathan E Rosenberg, including the following topics:

• Introduction (0:00)
• Overview; Localized Urothelial Bladder Cancer (UBC) (3:56)
• First-Line Treatment of Metastatic Disease (34:16)
• Sequencing of Therapy for Metastatic UBC (59:44)

NCPD information and select...